DSUVIA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dsuvia, and what generic alternatives are available?
Dsuvia is a drug marketed by Acelrx Pharms and is included in one NDA. There are eighteen patents protecting this drug.
This drug has ninety-two patent family members in nineteen countries.
The generic ingredient in DSUVIA is sufentanil citrate. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sufentanil citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dsuvia
A generic version of DSUVIA was approved as sufentanil citrate by HIKMA on December 15th, 1995.
Summary for DSUVIA
| International Patents: | 92 |
| US Patents: | 18 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 20 |
| Clinical Trials: | 3 |
| Patent Applications: | 6,228 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DSUVIA |
| What excipients (inactive ingredients) are in DSUVIA? | DSUVIA excipients list |
| DailyMed Link: | DSUVIA at DailyMed |
Recent Clinical Trials for DSUVIA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| United States Department of Defense | Phase 3 |
| Frank Guyette | Phase 3 |
| Montefiore Medical Center | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for DSUVIA
US Patents and Regulatory Information for DSUVIA
DSUVIA is protected by eighteen US patents.
Patents protecting DSUVIA
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Storage and dispensing devices for administration of oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small-volume oral transmucosal dosage forms
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Bioadhesive drug formulations for oral transmucosal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF ACUTE PAIN
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Acelrx Pharms | DSUVIA | sufentanil citrate | TABLET;SUBLINGUAL | 209128-001 | Nov 2, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for DSUVIA
See the table below for patents covering DSUVIA around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008085765 | See Plans and Pricing | |
| European Patent Office | 2808005 | Dispositifs de stockage et de distribution destinés à l'administration de formes pharmaceutiques transmucosiques orales (Storage and dispensing devices for administration of oral transmucosal dosage forms) | See Plans and Pricing |
| Portugal | 2367537 | See Plans and Pricing | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for DSUVIA
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2114383 | SPC/GB16/004 | United Kingdom | See Plans and Pricing | PRODUCT NAME: SUFENTANIL; REGISTERED: UK EU/1/15/1042 20150922 |
| 2114383 | CA 2016 00007 | Denmark | See Plans and Pricing | PRODUCT NAME: SUFENTANIL, HERUNDER SUFENTANIL SOM CITRAT; REG. NO/DATE: EU/1/15/1042/001-006 20150922 |
| 2114383 | 122016000023 | Germany | See Plans and Pricing | PRODUCT NAME: SUFENTANIL, WAHLWEISE IN FORM VON SUFENTANILCITRAT; REGISTRATION NO/DATE: EU/1/15/1042 20150918 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
